top of page
Head shot_Kimi_2025.png

Kimberly Negrin, PhD

Executive Director, Healthcare (Biotech & Medtech)

  • Linkedin

Kimberly is apart of TimeX's BioTech & MedTech sector of Healthcare, bringing in over a decade of leadership at the interesection of science, strategy and commercialization. She has built a career guiding life sciences and biotech companies through market entry, strategic growth, and brand positioning—helping translate bold scientific ideas into impactful commercial ventures and is continuing to impact the Healthcare space through her work at TimeX.

 

She is the Founder of Bloom Bio, a boutique consultancy specializing in technology advisory, commercialization strategy, fractional leadership, and executive coaching for life science companies. Her approach uniquely blends deep scientific expertise with practical business acumen, enabling early-stage and growth-stage innovators to accelerate their impact.

​

A passionate advocate for leadership development, Kimberly is dedicated to coaching technical founders and underserved entrepreneurs, particularly women in biotech. She also serves as a judge, mentor, and faculty member for the Biotools Innovator Accelerator, the world’s largest accelerator focused exclusively on BioTools, and has held advisory roles across cell therapy, regenerative medicine, and industry associations such as the Association for Women in Science (AWIS).

​

Kimberly earned her PhD in Biomedical Science from the University of Massachusetts Medical School, where her research focused on immunometabolism and lipid-based delivery systems, including liposome protocols foundational to today’s lipid nanoparticle technologies.

​

Securities are offered through Finalis Securities LLC Member FINRA / SIPC.  TimeX Capital LLC is not a registered broker-dealer, and Finalis Securities LLC and TimeX Capital LLC are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.

Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck | Finalis Form Customer Relationship Summary (“Form CRS”)

timexcapital.com (the "TimeX Capital LLC Website") is a website operated by TimeX Capital LLC. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and TimeX Capital LLC along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.

Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis’ Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.

bottom of page